Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Ann Rheum Dis13453 passages
• Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals Jog30 passages
• Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis Emery Paul 12Sebba Anthony 3Huizinga27 passages
• Campaign National Primary Care Centre, Keele University, Stoke on Trent, UKCorrespondence to Dr Anne Barton, Arthritis18 passages
• Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis? Extended reportHider S L25 passages
• Center, Berlin, Germany4 Division of Rheumatology, University of Pennsylvania, Philadelphia, USA5 Former Employee, Pfizer/Wyeth Pharmaceuticals, USACorrespondence to27 passages
• Center, Department of Development and20 passages
• Center, Ocala, USA6 Translational Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, USACorrespondence to:16 passages
• Center, University of Texas Southwestern Medical Center, Dallas, Texas, USAHandling editor32 passages
• Centre and Charité University Medicine, Berlin, GermanyCorrespondence to Professor48 passages
• Centre for Ageing, Newcastle University, Newcastle upon Tyne, UK2 Rheumatology department, University Hospital Birmingham, Birmingham, UK3 Rheumatology department, Great Western27 passages
• Centre of the University of Montreal Hospital Centre, Montreal, Canada8 Department of Social and Preventive Medicine, Université de Montréal, Montréal, CanadaCorrespondence to William Dixon, Arthritis30 passages
• Centre, Central Manchester University40 passages
• Centre, Glasgow, UKHandling editor28 passages
• Centre, Great Ormond Street Hospital for41 passages
• Centre, Hertfordshire, UK6 GlaxoSmithKline Research and Development, Stevenage, Hertfordshire, UKCorrespondence to Dr30 passages
• Centre, INSERM CIC03, Grenoble, France5 University of Toulouse, Toulouse, FranceCorrespondence to Professor Jean-Luc Bosson, Clinical Research Centre, CHU de20 passages
• Centre, Leeds Teaching142 passages
• Centre, Manchester31 passages
• Centre, Manchester Academic Health Science Centre, Manchester35 passages
• Centre, Manchester University42 passages
• Centre, Manchester, UK3 Dermatological Sciences, Salford19 passages
• Centre, University Hospitals35 passages
• Centre, University of Oxford Institute of Musculoskeletal Sciences, Oxford, UK5 Clinical and Academic Rheumatology, King's College22 passages
• Centre, University of Southampton, Southampton, UK17 NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital12 passages
• Collaboration (Epidemiology Group), School of Medicine and Dentistry, University of Aberdeen, UKCorrespondence to Dr24 passages
• Concise reportAdalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis Burmester19 passages
• Concise reportAnkylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2)17 passages
• Concise reportDevelopment of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project Stoffer18 passages
• Concise reportDifferential DNA methylation and expression of inflammatory and zinc transporter genes defines subgroups of osteoarthritic hip patients Rushton14 passages
• Concise reportElevated calprotectin levels reveal bowel inflammation in spondyloarthritis21 passages
• Concise reportExacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A14 passages
• Concise reportGolimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study Deodhar Atul 1Braun Jürgen 2Inman14 passages
• Concise reportHigh-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis Tan Ai Lyn Fukuba Eiji Halliday Nicola Ann Tanner15 passages
• Concise reportIncreased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease Culver14 passages
• Concise reportSustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis Peterfy Charles 1Burmester17 passages
• Concise reportTargeted deletion of Atg5 in chondrocytes promotes age-related osteoarthritis Bouderlique Thibault 1Vuppalapati13 passages
• Concise reportThe cellular composition of lymph nodes in the earliest phase of inflammatory arthritis van15 passages
• Concise reportThe genetic contribution to severe post-traumatic osteoarthritis Valdes16 passages
• Concise reportTofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors16 passages
• Consortium of Canada (SPARCC) SIJ structural score (SSS) on T1-weighted MRI. Change in SPARCC SSS and correlation with improvement in clinical outcomes was evaluated.27 passages
• Consortium of Canada (SPARCC) score for sacroiliac joints (SIJ) and the Berlin spinal score (remission defined as SPARCC <2 and Berlin ≤2, respectively).29 passages
• Council and Konung35 passages
• CouncilMRC000985http://dx.doi.org/10.13039/501100004063Knut och Alice Wallenbergs Stiftelsehttp://dx.doi.org/10.13039/501100004359Vetenskapsrådethttp://dx.doi.org/10.13039/501100007857Stiftelsen Konung28 passages
• Datalink Yu Dahai 1Jordan28 passages
• Datalink http://orcid.org/0000-0002-3859-7354Nakafero Georgina 1Grainge17 passages
• Europe, St Germain en Laye, France8 Institute of Rheumatology, Prague, Czech RepublicCorrespondence to:26 passages
• Extended ReportAutophagy is activated in systemic lupus erythematosus and required for plasmablast development Clarke29 passages
• Extended ReportEvidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study33 passages
• Extended ReportExpression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis24 passages
• Extended ReportGlucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence Poulsen32 passages
• Extended ReportHumoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA) Bingham15 passages
• Extended reportA meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip Evangelou Evangelos 12Kerkhof27 passages
• Extended reportA psychometric analysis of outcome measures in peripheral spondyloarthritis Turina28 passages
• Extended reportA randomised trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions Callaghan26 passages
• Extended reportA weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk Yarwood Annie 1Han Buhm 2Raychaudhuri Soumya 12Bowes John 1Lunt Mark 1Pappas29 passages
• Extended reportAMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis Bonnet31 passages
• Extended reportAmelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function Irmler22 passages
• Extended reportAn ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation Roberts24 passages
• Extended reportApremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3) Edwards36 passages
• Extended reportAssessment of disease activity in patients with rheumatoid arthritis using optical spectral transmission measurements, a non-invasive imaging technique van25 passages
• Extended reportAutoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism Wigerblad Gustaf 1Bas29 passages
• Extended reportAutologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis31 passages
• Extended reportAxial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis Jadon31 passages
• Extended reportBlocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis Nwosu34 passages
• Extended reportCertolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial29 passages
• Extended reportClinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study Maksymowych33 passages
• Extended reportClinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study31 passages
• Extended reportClinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort Parker Ben 1Urowitz27 passages
• Extended reportClinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study Dougados Maxime 1Kissel Karsten 2Conaghan31 passages
• Extended reportCombined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib Hochberg29 passages
• Extended reportComorbidities in patients with gout prior to and following diagnosis: case-control study Kuo Chang-Fu 12Grainge30 passages
• Extended reportComparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis Gabay Cem 1McInnes23 passages
• Extended reportComparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study31 passages
• Extended reportCrystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis Montgomery26 passages
• Extended reportDemographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population Verstappen29 passages
• Extended reportDevelopment of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project Stoffer24 passages
• Extended reportDrug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab26 passages
• Extended reportDual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study Bongartz Tim 1Glazebrook24 passages
• Extended reportDysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr−/− mice Wilhelm23 passages
• Extended reportDysregulated bioenergetics: a key regulator of joint inflammation27 passages
• Extended reportEarly remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register Scirè26 passages
• Extended reportEffect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)32 passages
• Extended reportEffect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study McInnes28 passages
• Extended reportEffects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation Kirkham32 passages
• Extended reportEffects of needs-based patient education on self-efficacy and health outcomes in people with rheumatoid arthritis: a multicentre, single blind, randomised controlled trial31 passages
• Extended reportEfficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial Wallace33 passages
• Extended reportEfficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial Burmester Gerd-Rűdiger 1Kivitz28 passages
• Extended reportEfficacy and safety of mavrilimumab in subjects with rheumatoid arthritis Burmester27 passages
• Extended reportEfficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study Genovese34 passages
• Extended reportEfficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA) Burmester24 passages
• Extended reportEfficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial Brunner36 passages
• Extended reportEvaluation of the RABBIT Risk Score for serious infections17 passages
• Extended reportEvaluation of the genetic overlap between osteoarthritis with body mass index and height using genome-wide association scan data Elliott28 passages
• Extended reportEvidence for treating rheumatoid arthritis to target: results of a systematic literature search update Stoffer21 passages
• Extended reportExpression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis28 passages
• Extended reportFactors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort Bruce31 passages
• Extended reportFamilial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan Kuo Chang-Fu 12Grainge23 passages
• Extended reportFine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases31 passages
• Extended reportFull dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis van Vollenhoven25 passages
• Extended reportGenetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications Ombrello29 passages
• Extended reportGenome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes Imgenberg-Kreuz Juliana 1Sandling29 passages
• Extended reportGenome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region Basic and translational researchPeters38 passages
• Extended reportHead-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial Schiff Michael 1Weinblatt35 passages
• Extended reportHistone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes Angiolilli Chiara 12Kabala22 passages
• Extended reportHow common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition Shoop-Worrall30 passages
• Extended reportIL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis Anderson29 passages
• Extended reportIdentification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis Schwenzer Anja 1Jiang Xia 2Mikuls27 passages
• Extended reportIdentification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis Xie Gang 13Lu Yue 2Sun Ye 13Zhang Steven Shiyang 1Keystone Edward Clark 3Gregersen24 passages
• Extended reportImpact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort Parker Ben 12Urowitz25 passages
• Extended reportImpact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis31 passages
• Extended reportIncreased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain28 passages
• Extended reportIncreased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink Clarson25 passages
• Extended reportInternational comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and Sweden Jordan29 passages
• Extended reportInternational patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials Orbai Ana-Maria 1de Wit Maarten 2Mease Philip 3Shea32 passages
• Extended reportIs cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database Muller Sara Hider18 passages
• Extended reportLong-term safety of pegloticase in chronic gout refractory to conventional treatment Becker27 passages
• Extended reportLong-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients van Vollenhoven30 passages
• Extended reportLong-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials Cohen28 passages
• Extended reportLow-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) Buttgereit Frank 1Mehta Daksha 2Kirwan John 3Szechinski Jacek 4Boers Maarten 5Alten33 passages
• Extended reportLupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial Zimmer Robert 1Scherbarth27 passages
• Extended reportMICL controls inflammation in rheumatoid arthritis Redelinghuys Pierre 1Whitehead Lauren 1Augello Andrea 1Drummond23 passages
• Extended reportMethotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation34 passages
• Extended reportMxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome Maria31 passages
• Extended reportNerve growth factor inhibition with tanezumab influences weight-bearing and subsequent cartilage damage in the rat medial meniscal tear model LaBranche27 passages
• Extended reportNitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness Yamada Takashi 12Fedotovskaya Olga 1Cheng31 passages
• Extended reportOsteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis Sagar Devi Rani 1Ashraf Sadaf 2Xu Luting 1Burston28 passages
• Extended reportPKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth Kc Ranjan 1Li Xin 1Kroin27 passages
• Extended reportPeg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 Saadoun David 12Resche26 passages
• Extended reportPreclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis24 passages
• Extended reportPrediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment Rech Juergen 1Hueber25 passages
• Extended reportPreferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA Zhao Jian 1Giles35 passages
• Extended reportPresence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands van28 passages
• Extended reportPrevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression Brkic Zana 1Maria30 passages
• Extended reportPrivate rare deletions in SEC16A and MAMDC4 may represent novel pathogenic variants in familial axial spondyloarthritis O'Rielly26 passages
• Extended reportProteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology Huesa Carmen 1Ortiz26 passages
• Extended reportQuality indicators for the primary care of osteoarthritis: a systematic review37 passages
• Extended reportQuantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate http://orcid.org/0000-0003-2497-4080Humphreys20 passages
• Extended reportRadiographic endophenotyping in hip osteoarthritis improves the precision of genetic association analysis Panoutsopoulou Kalliope 1Thiagarajah Shankar 2Zengini Eleni 23Day-Williams32 passages
• Extended reportRandomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial de34 passages
• Extended reportRelationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis Low32 passages
• Extended reportRising burden of gout in the UK but continuing suboptimal management: a nationwide population study Kuo Chang-Fu 12Grainge29 passages
• Extended reportRisk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs30 passages
• Extended reportRisk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers Mercer21 passages
• Extended reportRisk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Mercer28 passages
• Extended reportRisk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Mercer29 passages
• Extended reportRole of vascular channels as a novel mechanism for subchondral bone damage at cruciate ligament entheses in osteoarthritis and inflammatory arthritis26 passages
• Extended reportSAMHD1 prevents autoimmunity by maintaining genome stability Kretschmer Stefanie 1Wolf Christine 1König Nadja 1Staroske Wolfgang 2Guck Jochen 23Häusler Martin 4Luksch Hella 1Nguyen23 passages
• Extended reportSafety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate Keystone32 passages
• Extended reportSarilumab for the treatment of ankylosing spondylitis: results of a26 passages
• Extended reportSifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study Khamashta Munther 1Merrill35 passages
• Extended reportSmoking and overweight determine the likelihood of developing rheumatoid arthritis de Hair21 passages
• Extended reportSugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout Batt Caitlin 1Phipps-Green26 passages
• Extended reportSuppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus Parker Ben 1Al-Husain Awal 1Pemberton Philip 2Yates23 passages
• Extended reportSynovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis25 passages
• Extended reportSynovial tissue volume: a treatment target in knee osteoarthritis (OA) O'Neill32 passages
• Extended reportT cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals27 passages
• Extended reportThe JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis25 passages
• Extended reportThe comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor Harrold27 passages
• Extended reportThe effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a mendelian randomisation study Panoutsopoulou Kalliope 1Metrustry Sarah 2Doherty20 passages
• Extended reportThe effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis Winthrop29 passages
• Extended reportThe effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy Conaghan24 passages
• Extended reportThe genetic association of RUNX3 with ankylosing spondylitis can be explained by allele-specific effects on IRF4 recruitment that alter gene expression Vecellio Matteo 123Roberts26 passages
• Extended reportThe histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis Cowden25 passages
• Extended reportThe intervertebral disc contains intrinsic circadian clocks that are regulated by age and cytokines and linked to degeneration Dudek Michal 12Yang Nan 12Ruckshanthi21 passages
• Extended reportThe phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry26 passages
• Extended reportTocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial Burmester35 passages
• Extended reportTofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme Curtis31 passages
• Extended reportToll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors Ciechomska Marzena 1Huigens29 passages
• Extended reportTransient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation http://orcid.org/0000-0002-9208-9131Alawi28 passages
• Extended reportTreatment of diffuse systemic sclerosis with hyperimmune caprine serum (AIMSPRO): a phase II double-blind placebo-controlled trial28 passages
• Extended reportTreatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression27 passages
• Extended reportTreatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor Kavanaugh Arthur 1Mease32 passages
• Extended reportTreatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) Herrick29 passages
• Extended reportTuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis28 passages
• Extended reportUnderlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis Bomer Nils 12den Hollander Wouter 1Ramos23 passages
• Extended reportUpdate on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials34 passages
• Extended reportValidation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease Varsani Hemlata 1Charman31 passages
• Extended reportValidation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes Piram Maryam 1Koné-Paut Isabelle 1Lachmann20 passages
• Extended reportValidity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis Mcerlane Flora 12Beresford29 passages
• Group and Arthritis31 passages
• Group), Newcastle University, Newcastle upon Tyne, UK2 Musculoskeletal Directorate, Newcastle upon Tyne34 passages
• Group, Arthritis30 passages
• Group, Centre for Translational Inflammation Research, University of Birmingham, Birmingham, UKHandling editor25 passages
• Group, Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UKCorrespondence to:30 passages
• Group, Newcastle University, Newcastle upon Tyne, UK11 The Newcastle upon Tyne11 passages
• Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK10 Wellcome Trust Clinical Research Facility, University Hospitals27 passages
• Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK3 Merck40 passages
• HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE Caza34 passages
• Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate Concise reportKavanaugh A 1Klareskog L 2van der14 passages
• Institute /Reade, Amsterdam, Noord Holland, The Netherlands3 Westfriesgasthuis, Hoorn, The NetherlandsHandling editor32 passages
• Institute Reade, Amsterdam, The NetherlandsCorrespondence to Professor27 passages
• Institute Tasmania, Hobart, Australia31 Columbia University Medical Center, New York, New York, USA32 Leiden University Medical Center, Leiden, The NetherlandsHandling editor29 passages
• Institute for Primary Care and Health Sciences, Keele University, Keele, UK6 Arthritis21 passages
• Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK; c.pitzalis@qmul.ac.uk; Dr43 passages
• Institute, Kenilworth, New Jersey, USACorrespondence to:32 passages
• Institute, Maastricht, The Netherlands3 Wyeth Research, Collegeville, Pennsylvania, USA4 Department of Rheumatology, Leiden University Medical Center, Leiden, The NetherlandsCorrespondence to:22 passages
• Institute, University Health Network, Toronto, Ontario, CanadaCorrespondence to:24 passages
• Institute, Vancouver, Canada3 Arthritis31 passages
• Institute, Vizcaya, Spain12 University of Alabama at Birmingham, Birmingham, Alabama, USA1345 passages
• Laboratories and Clinical Academic Unit of Rheumatology, Department of Internal Medicine, University of Genova, Viale15 passages
• Laboratory and Academic Clinical Unit of Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy9 Department of22 passages
• Laboratory, Department of Clinical Science, University of Bergen, The Laboratory Building, 5th floor,29 passages
• Leeds Biomedical Research Centre, Leeds Teaching31 passages
• Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching20 passages
• Manchester Biomedical Research Centre, Central Manchester University30 passages
• Manchester Musculoskeletal Biomedical Research Centre, Manchester University18 passages
• Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials Extended reportSalliot C28 passages
• Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide Wythe24 passages
• The changing landscape of biosimilars in rheumatology Dörner Thomas 12Strand Vibeke 3Cornes Paul 4Gonçalves João 5Gulácsi László 6http://orcid.org/0000-0002-8970-4260Kay Jonathan 7Kvien36 passages
• Triangle Park, North Carolina, USA7 Human Genome Sciences, Inc, Rockville, Maryland, USACorrespondence to27 passages
• UK Centre for Adolescent Rheumatology, University College London, London, UK2 Adolescent Rheumatology Department, University College London10 passages
• UK Epidemiology Unit, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UKCorrespondence to Professor Jane Worthington, Arthritis29 passages
• UK Epidemiology Unit, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK2 Norfolk Arthritis Register, School of Medicine Health Policy and Practice Faculty of22 passages
• UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UKCorrespondence to Dr Kimme Hyrich, Arthritis15 passages
• UK Epidemiology Unit, The University of Manchester, Manchester, UK2 Dermatological Sciences, Salford20 passages
• UK Epidemiology Unit, The University of Manchester, Manchester, UK2 Norfolk Arthritis Register, School of Medicine Health Policy and Practice, University of East Anglia, Norwich, UKCorrespondence to16 passages
• UK Epidemiology Unit, The University of Manchester, Manchester, UKCorrespondence to Dr26 passages
• UK Epidemiology Unit, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UKCorrespondence to19 passages
• UK Pain Centre, School of Biomedical Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UKCorrespondence to25 passages
• UK Primary Care Centre, Keele University, Keele, UK2 Centre for Health Sciences Research, University of Salford, Salford, UKHandling editor35 passages
• UK Primary Care Centre, Keele University, Keele, UKCorrespondence to Professor Anne Barton, Arthritis15 passages
• UK Primary Care Centre, Keele University, Keele, UKHandling editor21 passages
• UK Primary Care Centre, Primary Care Sciences, Keele University, Staffordshire, UK2 Department of Rheumatology, Leiden University Medical Center, Leiden, The NetherlandsHandling editor25 passages
• Unit on Psoriatic Arthritis, Department of Clinical Medicine and Surgery,23 passages
• Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK11 Faculty of Medical and Human Sciences, Arthritis15 passages
• Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UKHandling editor55 passages
• Unit, Central Manchester University70 passages
• Unit, Fundación Española de Reumatología, Madrid, Spain5 Paris Descartes University, Medicine Faculty; UPRES-EA 4058; APHP,27 passages
• Unit, LTHT, University of Leeds, Leeds, UKHandling editor27 passages
• Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK4 Clinical and Academic Rheumatology Department, Kings College5 passages
• Unit, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK4 Clinical and Academic Rheumatology, Kings College15 passages
• Unit, Leeds Teaching500 passages
• Unit, Leeds, UK3 Leeds Teaching18 passages
• Unit, London School of Hygiene and Tropical Medicine, London, UKCorrespondence to Professor Michael Schirmer, Department of Internal29 passages
• Unit, Manchester Academic Health Science Centre, Manchester, UK5 Arthritis22 passages
• Unit, National Institute of Health Research Manchester, Central26 passages
• Unit, The Rayne Institute, King's College London School of Medicine, LondonUK3 Arthritis8 passages
• Unit, University of Leeds, Leeds, UK9 University of Toronto, Toronto, Ontario, Canada10 Leiden University Medical Center, Leiden, The NetherlandsCorrespondence to26 passages
• Value of biomarkers in osteoarthritis: current status and perspectives33 passages